You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES
NEWS / EVENTS / .........

EVENTS - 29-11-2011

Kedrions wins the "Transatlantic Award 2011" of the American Chamber of Commerce in Italy

Last night, the President of the American Chamber of Commerce in Italy, Vittorio Terzi, gave Paolo Marcucci, President and CEO of Kedrion, the “Transatlantic Award 2011” for the company’s response to the challenges of the international market by investing in quality and technological innovation and for its success in the US market.

In 2011, Kedrion Group, through the newly-established Kedrion Biopharma, acquired from Grifols a plasma-fractionation plant in Melville (State of New York) and two US plasma collection centres (in Mobile, Alabama, and in Winston Salem, North Carolina).
 
The “Transatlantic Award” is an important prize that the Italy-USA community awards to businessmen, management or cultural figures that have stood out for promoting the development of transatlantic relations between Italy and the United States.
 
«We are very glad for this award – Paolo Marcucci comments –, because, with such acquisitions, we have proven that the Group is committed to strengthening its role on the global market and gaining a share of a market, the US one, where quality standards are among the highest in the world. Kedrion had already been present in the overseas market for years through the plasma collection centres of Kingsport, Bristol and Johnson City in Tennessee, Reseda in California, Pensacola in Florida and Mobile in Alabama, but the acquisition of Grifols’ assets has been a definite improvement, which has also made us get a 300,000-litre contract manufacturing agreement for the fractionation and purification of Kedrion’s  own plasma for the manufacture and sale of plasma-derived medicinal products in the USA»

«In parallel with such operation – Marcucci adds –, we completed a plan for the registration of our Albumin on the North American market, and we are going on with our plans for increasing the number of our plasma collection centres. On a global scale, our growth and development plan includes covering new foreign markets, strengthening the European ones, and retaining our leadership in Italy. We pursue these goals with commitment, care for product quality and excellent technological standards that are our distinguishing features».

For more information please contact: pressoffice@kedrion.com